147 results on '"Goldman, M."'
Search Results
2. Functionality, reliability, and performance of an accessorised pre-filled syringe with home-administered subcutaneous benralizumab for adult patients with severe asthma: P69
3. Our older population: donors as well as recipients?
4. Understanding iron depletion and overload in blood donors
5. Development of standard definitions for surveillance of complications related to blood donation
6. Donor attention to reading materials
7. Iron depletion and routine ferritin measurement in blood donors
8. DONOR ATTENTION TO PRE-DONATION READING MATERIALS: 3D-S21-05
9. Allowing blood donation from men who had sex with men more than 5 years ago: a model to evaluate the impact on transfusion safety in Canada
10. Measuring respiratory symptoms in clinical trials of COPD: reliability and validity of a daily diary
11. Bacterial contamination in platelet concentrates
12. The epidemiology of human T-cell lymphotropic virus types I and II in Canadian blood donors
13. Donor selection for recipient safety
14. DONOR MOTIVATIONAL FACTORS PREDICTING DONOR RETURN AFTER MALARIA RISK TRAVEL DEFERRAL: AN APPLICATION OF PATH ANALYSIS: 3D-S26-06
15. Cyclosporine A Drives a Th17- and Th2-Mediated Posttransplant Obliterative Airway Disease
16. The impact of increasing the upper age limit of donation on the eligible blood donor population in Canada
17. Measures to prevent transfusion-related acute lung injury (TRALI)
18. A RANDOMISED, OPEN LABEL PHASE 3 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF A DRY POWDER FORMULATION OF COLISTIMETHATE SODIUM (COLOBREATHE®) VERSUS TOBRAMYCIN NEBULISER SOLUTION (TNS) IN CYSTIC FIBROSIS SUBJECTS WITH CHRONIC PSEUDOMONAS AERUGINOSA LUNG INFECTION: 363★
19. Correlation of Blood Donor RhD Negative Typing Results Using Two Automated Platforms, Serology and Genotyping: SP292
20. Iron Stores in Whole Blood Donors: SP98
21. Iron Stores in Female Donors Failing Initial Fingerstick Hemoglobin Determination: SP93
22. DEL BLOOD DONORS ALLOIMMUNISED PATIENTS: THE CANADIAN EXPERIENCE: 3C-S8–03
23. The Innovative Medicines Initiative: A European Response to the Innovation Challenge
24. Th17 Alloimmunity Prevents Neonatal Establishment of Lymphoid Chimerism in IL-4-Deprived Mice
25. Deferral of males who had sex with other males
26. Deferral of males who had sex with other males
27. Quality controls of cryopreserved haematopoietic progenitor cells (peripheral blood, cord blood, bone marrow)
28. Evaluation of Screening Questions for Chagas Disease Risk: SP417
29. Mixed Field Reactions in ABO and Rh Typing Due to Chimerism Resulting from Twin Hematopoiesis: SP265
30. Evaluation of the DiaMed ID-PaGIA Microtyping System for Detecting Severe Immunoglobulin A Deficiency and Anti-Human IgA Antibodies: SP226
31. Monitoring the Safety of Donors Participating in a Plasmapheresis Program (2004-2010): SP98
32. Expansion of regulatory CD8+CD25+ T cells after neonatal alloimmunization
33. Onset of Action of Two ICS/LABA Combinations as Measured by Impulse Oscillometry (IOS) in Young Adults with Asthma: 598
34. Physical inactivity, neurological disability, and cardiorespiratory fitness in multiple sclerosis
35. Platelet Donor Selection (PDS) efficacy in platelet transfusion: one centre experience: T7-PO73
36. TRALI Investigations and monitoring at Canadian Blood Services: T6-PO82
37. Making Maps Reduces Recalls: AP16
38. YOUTH ALCOHOL SCREENING WORKGROUP II: DETERMINING OPTIMAL SECONDARY SCREENING QUESTIONS: 092
39. Evaluation of the confidential unit exclusion form: the Canadian Blood Services experience
40. Understanding non-disclosure of deferrable risk: a study of blood donors with a history of intravenous drug use
41. HUMAN T LYMPHOTROPIC VIRUS IN CANADIAN BLOOD DONORS: 3A-S10-04
42. Impact of High Blood Pressure Defferal on Donor Decision to Seek Medical Attention: AP32
43. Evaluation of the Safety Benefit of Confidential Unit Exclusion: SP455
44. Screening of Canadian Blood Services Donors for Severe IgA Deficiency: SP362
45. Evidence of Patient Specific HLA Antibodies in Canadian TRALI Cases Classified by the 2004 Canadian Consensus Conference Definition: S107-040D
46. TRALI Prevention at Canadian Blood Services: The Evolving Process and Its Impact on TRALI Cases in Canada: S112-040D
47. Bacterial Screening of Outdated Buffy Coat Platelet Pools Using the Bact/ALERT System and Verax Platelet PGD Test: S106-040C
48. Endotoxin-Induced Myeloid-Derived Suppressor Cells Inhibit Alloimmune Responses via Heme Oxygenase-1
49. Bulging fontanelle in febrile infants: is lumbar puncture mandatory?
50. Basophil activation tests for the diagnosis of food allergy in children
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.